EGFR and neoplasm: Further investigation of the intracellular signalling pathways involved in the hEGR1 induction by EGF and its inhibition by gefitinib would clarify the role of hEGR1 in EGFR-dependent tumour growth and progression and its inhibition by gefitinib.